nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

31.01.2019 | Original Paper

Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies

verfasst von: Valentina Lorenzetti, Yann Chye, Pedro Silva, Nadia Solowij, Carl A. Roberts

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Regular cannabis use is associated with adverse cognitive and mental health outcomes that have been ascribed to aberrant neuroanatomy in brain regions densely innervated with cannabinoid receptors. Neuroanatomical differences between cannabis users and controls have been assessed in multiple structural magnetic resonance imaging (sMRI) studies. However, there is heterogeneity in the results leading to cautious interpretation of the data so far. We examined the sMRI evidence to date in human cannabis users, to establish more definitely whether neuroanatomical alterations are associated with regular cannabis use. The regional specificity and association with cannabis use indices (i.e. cumulative dosage, duration) were also explored. We systematically reviewed and meta-analysed published sMRI studies investigating regional brain volumes (cortical, subcortical and global) in cannabis users and non-user controls. Three electronic databases were searched (PubMed, Scopus, and PsycINFO). A total of 17 meta-analyses were conducted (one for each cortical, subcortical and global volume) using the generic inverse variance method, whereby standardised mean difference in volume was calculated between users and non-users. Exploratory meta-regressions were conducted to investigate the association between cannabis use indices and regional brain volumes. A total of 30 articles were eligible for inclusion, contributing 106 effect sizes across 17 meta-analyses. Regular cannabis users had significantly smaller volumes of the hippocampus (SMD = 0.14, 95% CIs [0.02, 0.27]; Z = 2.29, p = 0.02, I² = 74%) and orbitofrontal cortex {medial (SMD = 0.30, 95% CIs [0.15, 0.45]; Z = 3.89, p = 0.0001, I² = 51%), lateral (SMD = 0.19, 95% CIs [0.07, 0.32]; Z = 3.10, p = 0.002, I² = 26%)} relative to controls. The volumes of the hippocampus and orbitofrontal cortex were not significantly associated with cannabis duration and dosage. Our findings are consistent with evidence of aberrance in brain regions involved in reward, learning and memory, and motivation circuits in the regular use of substances other than cannabis, pointing to commonality in neurobiological abnormalities between regular users of cannabis and of other substances.

Nur mit Berechtigung zugänglich

Adamson SJ, Sellman JD (2003) A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev 22(3):309–315. https://doi.org/10.1080/0959523031000154454 CrossRefPubMed

APA (2013) DSM-V diagnostic and statistical manual of mental disorders, Fourth ed

Ashtari M, Avants B, Cyckowski L, Cervellione KL, Roofeh D, Cook P, Kumra S (2011) Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res 45(8):1055–1066. https://doi.org/10.1016/j.jpsychires.2011.01.004 CrossRefPubMedPubMedCentral

Batalla A, Lorenzetti V, Chye Y, Yücel M, Soriano-Mas C, Bhattacharyya S, Martín-Santos R (2018) The influence of DAT1, COMT, and BDNF genetic polymorphisms on total and subregional hippocampal volumes in early onset heavy cannabis users. Cannabis Cannabinoid Res 3(1):1–10. https://doi.org/10.1089/can.2017.0021 CrossRefPubMedPubMedCentral

Batalla A, Soriano-mas C, López-solà M, Torrens M, Crippa JA, Bhattacharyya S, Martín-santos R (2013) Modulation of brain structure by catechol-O-methyltransferase Val158Met polymorphism in chronic cannabis users. Addict Biol 19:722–732. https://doi.org/10.1111/adb.12027 CrossRefPubMed

Block RI, O’Leary DS, Ehrhardt JC, Augustinack JC, Ghoneim MM, Arndt S, Hall JA (2000) Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 11(3):491–496. https://doi.org/10.1097/00001756-200002280-00013 CrossRefPubMed

Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N (2016) Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiat 79(7):557–567. https://doi.org/10.1016/j.biopsych.2015.12.002 CrossRefPubMed

Budney AJ, Novy PL, Hughes JR (1999) Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 94:1311–1322. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10615717

Butters JE (2002) Family stressors and adolescent cannabis use: a pathway to problem use. J Adolesc 25:645–654CrossRefPubMed

10.

Ceccarini J, Casteels C, Koole M, Bormans G, Van Laere K (2013) Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study. Eur J Nucl Med Mol Imaging 40(10):1582–1594. https://doi.org/10.1007/s00259-013-2456-1 CrossRefPubMed

11.

Chambers RA (2013) Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders. Drug Alcohol Depend 130(1–3):1–12. https://doi.org/10.1016/j.drugalcdep.2012.12.005 CrossRefPubMed

12.

Cheetham A, Allen NB, Whittle S, Simmons JG, Yücel M, Lubman DI (2011) Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study. Biol Psychiatr 71(8):684–692. https://doi.org/10.1016/j.biopsych.2011.10.029 CrossRef

13.

Churchwell JC, Lopez-Larson MP, Yurgelun-Todd DA (2010) Altered frontal cortical volume and decision making in adolescent cannabis users. Front Psychol 1(December):1–8

14.

Chye Y, Lorenzetti V, Suo C, Batalla A, Cousijn J, Goudriaan AE, Solowij (2018) Alteration to hippocampal volume and shape confined to cannabis dependence: a multi-site study. Addict Biol. https://doi.org/10.1111/adb.12652 CrossRefPubMed

15.

Chye Y, Solowij N, Ganella EP, Suo C, Yücel M, Batalla A, Lorenzetti V (2017) Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms. Progress Neuropsychopharmacol Biol Psychiatry 79(July):392–400. https://doi.org/10.1016/j.pnpbp.2017.07.017 CrossRef

16.

Chye Y, Solowij N, Suo C, Batalla A, Cousijn J, Goudriaan AE, Yücel M (2017) Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users. Psychopharmacology 234(13):1985–1995. https://doi.org/10.1007/s00213-017-4606-9 CrossRefPubMed

17.

Chye Y, Suo C, Yücel M, den Ouden L, Solowij N, Lorenzetti V (2017) Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users. Psychopharmacology 234(14):2149–2157. https://doi.org/10.1007/s00213-017-4620-y CrossRefPubMed

18.

Chye Y, Suo C, Yücel M, den Ouden L, Solowij N, Lorenzetti V (2017) Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users. Psychopharmacology 2017:1–9

19.

Cousijn J, Wiers RW, Ridderinkhof KR, Brink W, Van Den Veltman DJ, Goudriaan AE (2012) Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. NeuroImage 59(4):3845–3851. https://doi.org/10.1016/j.neuroimage.2011.09.046 CrossRefPubMed

20.

Crippa JA, Zuardi AW, Martin-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P (2009) Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 24:515–523. https://doi.org/10.1002/hup.1048 CrossRefPubMed

21.

Crow TJ (2015) Cannabis and psychosis. Lancet Psychiatry 2:381–382CrossRefPubMed

22.

Curran HV, Hindocha C, Morgan CJA, Shaban N, Das RK, Freeman TP (2018) Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects? Psycholog Med 2018:1–7

23.

DeLisi LE (2008) The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry 21:140–150. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18332661

24.

DeLisi LE, Bertisch HC, Szulc KU, Majcher M, Brown K, Bappal A, Ardekani BA (2006) A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct J 3(17):1–6. https://doi.org/10.1186/1477-7517-3-17 CrossRef

25.

Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, Hermann D (2011) Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend 114(2–3):242–245. https://doi.org/10.1016/j.drugalcdep.2010.09.020 CrossRefPubMed

26.

Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634. https://doi.org/10.1136/bmj.316.7129.469 CrossRefPubMedPubMedCentral

27.

Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8(11):1481–1489. https://doi.org/10.1038/nn1579 CrossRefPubMed

28.

Filbey FM, Aslan S, Calhoun VD, Spence JS, Damaraju E, Caprihan A, Segall J (2014) Long-term effects of marijuana use on the brain. Proc Natl Acad Sci 111(47):16913–16918. https://doi.org/10.1073/pnas.1415297111 CrossRefPubMedPubMedCentral

29.

Filbey FM, McQueeny T, DeWitt SJ, Mishra V (2015) Preliminary findings demonstrating latent effects of early adolescent marijuana use onset on cortical architecture. Dev Cogn Neurosci 16:16–22. https://doi.org/10.1016/j.dcn.2015.10.001 CrossRefPubMedPubMedCentral

30.

Filbey FM, Mcqueeny T, Kadamangudi S, Bice C, Ketcherside A (2015) Combined effects of marijuana and nicotine on memory performance and hippocampal volume. Behav Brain Res 293:46–53. https://doi.org/10.1016/j.bbr.2015.07.029 CrossRefPubMedPubMedCentral

31.

Gage SH, Jones HJ, Burgess S, Bowden J, Smith GD, Zammit S, Munafò MR (2017) Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol Med 47:971–980CrossRefPubMed

32.

Gage SH, Matthew H, Zammit SG (2015) Association between cannabis and psychosis: epidemiological evidence. Biol Psychiat. https://doi.org/10.1016/j.biopsych.2015.08.001 CrossRefPubMed

33.

Gilman JM, Kuster JK, Lee S, Lee MJ, Kim BW, Makris N, … Breiter HC (2014) Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci 34(16):5529–5538. https://doi.org/10.1523/JNEUROSCI.4745-13.2014 CrossRefPubMedPubMedCentral

34.

Glass M, Faull RLM, Dragunow M (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299. http://www.sciencedirect.com/science/article/B6T0F-3R7J7K8-3/1/03800c9a48427626769c950488125aeb

35.

Gonzalez S, Cebeira M, Fernandez-Ruiz J (2005) Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav 81:300–318. https://doi.org/10.1016/j.pbb.2005.01.028 CrossRefPubMed

36.

Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W (2007) Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry 46:408–417CrossRefPubMed

37.

Hindocha C, Norberg MM, Tomko RL (2017) Solving the problem of cannabis quantification. Lancet 4:643–648

38.

Hindocha C, Shaban NDC, Freeman TP, Das RK, Gale G, Schafer G, Curran HV (2015) Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom. Drug Alcohol Depend 148:165–171. https://doi.org/10.1016/j.drugalcdep.2015.01.004 CrossRefPubMedPubMedCentral

39.

Hyman SM, Sinha R (2009) Stress-related factors in cannabis use and misuse: Implications for prevention and treatment. J Subst Abuse Treat 36(4):400–413. https://doi.org/10.1016/j.jsat.2008.08.005 CrossRefPubMed

40.

Koob GF (1999) The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci 877:445–460. https://doi.org/10.1111/j.1749-6632.1999.tb09282.x CrossRefPubMed

41.

Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–58CrossRefPubMed

42.

Koob GF, Volkow ND (2017) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3(8):760–773. https://doi.org/10.1016/S2215-0366(16)00104-8 CrossRef

43.

Köpetz CE, Lejuez CW, Wiers RW, Kruglanski AW (2013) Motivation and self-regulation in addiction: a call for convergence. Perspect Psychol Sci 8:3–24CrossRefPubMedPubMedCentral

44.

Kumra S, Robinson P, Tambyraja R, Jensen D, Schimunek C, Houri A, Lim K (2012) Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J Am Acad Child Adolesc Psychiatry 51(2):171–180. https://doi.org/10.1016/j.jaac.2011.11.001 CrossRefPubMed

45.

Lawson GM, Camins JS, Wisse L, Wu J, Duda JT, Cook PA, Farah MJ (2017) Childhood socioeconomic status and childhood maltreatment: distinct associations with brain structure. PLoS One 12(4):1–16. https://doi.org/10.6084/m9.figshare.4811404.Introduction CrossRef

46.

Lopez-Larson MP, Bogorodzki P, Rogowska J, McGlade E, King JB, Terry J, Yurgelun-Todd D (2011) Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav Brain Res 220(1):164–172. https://doi.org/10.1016/j.bbr.2011.02.001 CrossRefPubMedPubMedCentral

47.

Lorenzetti V, Cousijn J, Solowij N, Garavan H, Suo C, Verdejo-García A (2016) The neurobiology of cannabis use disorder: a call for evidence. Front Behav Neurosci 10(May):1–3. https://doi.org/10.3389/fnbeh.2016.00086 CrossRef

48.

Lorenzetti V, Solowij N, Suo C, Walterfang M, Lubman DI, Verdejo-García A, Yücel M (2016) Cannabis dependence and the brain reward system: disentangling the role of exposure and addiction related effects. Eur Neuropsychopharmacol 26:S701–S702. https://doi.org/10.1016/S0924-977X(16)31836-3 CrossRef

49.

Lorenzetti V, Alonso-Lana SJ, Youssef G, Verdejo-Garcia A, Suo C, Cousijn J, Solowij N (2016) Adolescent cannabis use: what is the evidence for functional brain alteration? Curr Pharm Des 22(42):6353–6365CrossRefPubMed

50.

Lorenzetti V, Solowij N, Whittle S, Fornito A, Lubman DI, Pantelis C, Yücel M (2015) Gross morphological brain changes with chronic, heavy cannabis use. Br J Psychiatry 206(1):77–78. https://doi.org/10.1192/bjp.bp.114.151407 CrossRefPubMed

51.

Lorenzetti V, Solowij N, Yücel M (2016) The role of cannabinoids in neuroanatomic alterations in cannabis users. Biol Psychiat 79(7):e17–e31. https://doi.org/10.1016/j.biopsych.2015.11.013 CrossRefPubMed

52.

Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434CrossRefPubMed

53.

Mashhoon Y, Sava S, Sneider JT, Nickerson LD, Silveri MM (2015) Cortical thinness and volume differences associated with marijuana abuse in emerging adults. Drug Alcohol Depend 155:275–283. https://doi.org/10.1016/j.drugalcdep.2015.06.016 CrossRefPubMedPubMedCentral

54.

Mata I, Perez-Iglesias R, Roiz-Santiañez R, Tordesillas-Gutierrez D, Pazos A, Gutierrez A, Crespo-Facorro B (2010) Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Res 1317:297–304. https://doi.org/10.1016/j.brainres.2009.12.069 CrossRefPubMed

55.

Matochik JA, Eldreth DA, Cadet J-L, Bolla KI (2005) Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 77(1):23–30. https://doi.org/10.1016/j.drugalcdep.2004.06.011 CrossRefPubMed

56.

Mcdonald RJ, Hong NS (2013) How does a specific learning and memory system in the mammalian brain gain control of behavior? Hippocampus 23(11):1084–1102. https://doi.org/10.1002/hipo.22177 CrossRefPubMed

57.

Mcqueeny T, Padula CB, Price J, Lisdahl K, Logan P, Tapert SF (2011) Gender effects on amygdala morphometry in adolescent marijuana users. Behav Brain Res 224(1):128–134. https://doi.org/10.1016/j.bbr.2011.05.031 CrossRefPubMedPubMedCentral

58.

Mechoulam R, Gaoni Y (1965) Hashish–IV: the isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 21:1223–1229. http://www.sciencedirect.com/science/article/B6THR-43DF3R8-17/2/d928f56af702f7355da872239e86e142

59.

Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang TT, Tapert SF (2009) Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol 14(4):457–468. https://doi.org/10.1111/j.1369-1600.2009.00166.x CrossRefPubMedPubMedCentral

60.

Medina KL, Nagel BJ, Park A, McQueeny T, Tapert SF (2007) Depressive symptoms in adolescents: associations with white matter volume and marijuana use. J Child Psychol Psychiatry 48(6):592–600. https://doi.org/10.1111/j.1469-7610.2007.01728.x CrossRefPubMedPubMedCentral

61.

Medina KL, Nagel BJ, Tapert SF (2010) Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res 182(2):152–159. https://doi.org/10.1016/j.pscychresns.2009.12.004 CrossRefPubMedPubMedCentral

62.

Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF (2007) Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol 29(1):141–152. https://doi.org/10.1055/s-0029-1237430.Imprinting CrossRefPubMed

63.

Moreno-Alcázar A, Gonzalvo B, Canales-Rodríguez EJ, Blanco L, Bachiller D, Romaguera A, Pomarol-Clotet E (2018) Larger gray matter volume in the basal ganglia of heavy cannabis users detected by voxel-based morphometry and subcortical volumetric analysis. Front Psychiatry 9(MAY):1–9. https://doi.org/10.3389/fpsyt.2018.00175 CrossRef

64.

Muhammad A, Carroll C, Kolb B (2012) Stress during development alters dendritic morphology in the nucleus accumbens and prefrontal cortex. Neuroscience 216:103–109. https://doi.org/10.1016/j.neuroscience.2012.04.041 CrossRefPubMed

65.

Nutt DJ, King LA, Phillips LD (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376(9752):1558–1565. https://doi.org/10.1016/S0140-6736(10)61462-6 CrossRefPubMed

66.

Paul S, Bhattacharyya S (2018) Does thinner right entorhinal cortex underlie genetic liability to cannabis use? Psychol Med. https://doi.org/10.1017/S0033291718000417 CrossRefPubMed

67.

Poulton R, Moffitt TE, Harrington H, Milne BJ, Caspi A (2001) Persistence and perceived consequences of cannabis use and dependence among young adults: implications for policy. N Z Med J 114(1145):544–547PubMed

68.

Price JS, McQueeny T, Shollenbarger S, Browning EL, Wieser J, Lisdahl KM (2015) Effects of marijuana use on prefrontal and parietal volumes and cognition in emerging adults. Psychopharmacology. https://doi.org/10.1007/s00213-015-3931-0 CrossRefPubMedPubMedCentral

69.

Ramirez DR, Savage LM (2007) Differential involvement of the basolateral amygdala, orbitofrontal cortex, and nucleus accumbens core in the acquisition and use of reward expectancies. Behav Neurosci 121:896CrossRefPubMedPubMedCentral

70.

Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 1141:1–21. https://doi.org/10.1196/annals.1441.020 CrossRefPubMed

71.

Robinson TE, Berridge KC (2008) The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc B Biol Sci 363(1507):3137–3146. https://doi.org/10.1098/rstb.2008.0093 CrossRef

72.

Rocchetti M, Crescini A, Borgwardt S, Caverzasi E, Politi P, Atakan Z, Fusar-Poli P (2013) Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. Psychiatry Clin Neurosci 67(7):483–492. https://doi.org/10.1111/pcn.12085 CrossRefPubMed

73.

Scallet AC (1991) Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals. Pharmacol Biochem Behav 40:671–676. https://doi.org/10.1016/0091-3057(91)90380-K CrossRefPubMed

74.

Schacht JP, Hutchison KE, Filbey FM (2012) Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology 37(11):2368–2376. https://doi.org/10.1038/npp.2012.92 CrossRefPubMedPubMedCentral

75.

Scott JC, Wolf DH, Calkins ME, Bach EC, Weidner J, Ruparel K, Gur RE (2017) Cognitive functioning of adolescent and young adult cannabis users in the Philadelphia Neurodevelopmental Cohort. Psychol Addict Behav 31:423CrossRefPubMedPubMedCentral

76.

Sjoerds Z, Luigjes J, Van Den Brink W, Denys D, Yücel M (2014) The role of habits and motivation in human drug addiction: a reflection. Front Psychiatry 5:8CrossRefPubMedPubMedCentral

77.

Solowij N, Lorenzetti V, Yücel M (2016) Effects of cannabis use on human behavior: a call for standardization of cannabis use metrics. JAMA Psychiatry 73(9):995–996. https://doi.org/10.1001/jamapsychiatry.2016.1805.Author CrossRefPubMed

78.

Solowij N, Walterfang M, Lubman DI, Whittle S, Lorenzetti V, Styner M, Yucel M (2013) Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophr Res 143:179–184. https://doi.org/10.1016/j.schres.2012.10.040 CrossRefPubMed

79.

Solowij N, Yücel M, Respondek C, Whittle S, Lindsay E, Pantelis C, Lubman DI (2011) Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychol Med 41(11):2349–2359. https://doi.org/10.1017/S003329171100050X CrossRefPubMed

80.

Terry-McElrath YM, O’Malley PM, Johnston LD (2013) Simultaneous alcohol and marijuana use among US high school seniors from 1976 to 2011: trends, reasons, and situations. Drug Alcohol Depend 133(1):71–79. https://doi.org/10.1016/j.drugalcdep.2013.05.031 CrossRefPubMedPubMedCentral

81.

Tzilos GK, Cintron CB, Wood JBR, Simpson NS, Young AD, Pope HG, Yurgelun-Todd DA (2005) Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict Am Acad Psychiatr Alcohol Addict 14(1):64–72. https://doi.org/10.1080/10550490590899862 CrossRef

82.

United Nations Office on Drugs and Crime (2016) World drug report 2016. In: United Nations publication. United Nations publication, Sales No. E.16.XI.7

83.

Verdejo-García A, Lawrence AJ, Clark L (2008) Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 32(4):777–810. https://doi.org/10.1016/j.neubiorev.2007.11.003 CrossRefPubMed

84.

Volkow ND, Fowler JS (2000) Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex (New York, N.Y.: 1991) 10(3):318–325. https://doi.org/10.1093/cercor/10.3.318 CrossRef

85.

Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Baler R (2016) Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry 73(3):292–297. https://doi.org/10.1001/jamapsychiatry.2015.3278 CrossRefPubMed

86.

Weiland XBJ, Thayer RE, Depue XBE, Sabbineni A, Bryan AD, Hutchison KE (2015) Daily marijuana use is not associated with brain morphometric measures in adolescents or adults. J Neurosci 35(4):1505–1512. https://doi.org/10.1523/JNEUROSCI.2946-14.2015 CrossRefPubMedPubMedCentral

87.

Wikenheiser AM, Schoenbaum G (2016) Over the river, through the woods: cognitive maps in the hippocampus and orbitofrontal cortex. Nat Rev Neurosci 17(8):513–523. https://doi.org/10.1038/nrn.2016.56 CrossRefPubMedPubMedCentral

88.

Yip SW, DeVito EE, Kober H, Worhunsky PD, Carroll KM, Potenza MN (2014) Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment. Drug Alcohol Depend 140(6):33–41. https://doi.org/10.1016/j.drugalcdep.2014.03.031 CrossRefPubMedPubMedCentral

89.

Ystrom E, Reichborn-Kjennerud T, Neale MC, Kendler KS (2014) Genetic and environmental risk factors for illicit substance use and use disorders: joint analysis of self and co-twin ratings. Behav Genet 44(1):1–13. https://doi.org/10.1007/s10519-013-9626-6 CrossRefPubMed

90.

Yücel M, Lorenzetti V, Suo C, Zalesky A, Fornito A, Takagi MJ, Solowij N (2016) Hippocampal harms, protection and recovery following regular cannabis use. Transl Psychiatry 6(1):e710. https://doi.org/10.1038/tp.2015.201 CrossRefPubMedPubMedCentral

91.

Yücel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DI (2008) Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 65(6):694–701CrossRefPubMed

Titel: Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies
verfasst von: Valentina Lorenzetti
Yann Chye
Pedro Silva
Nadia Solowij
Carl A. Roberts
Publikationsdatum: 31.01.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 1/2019
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-019-00979-1

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use

Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?

Cannabis use and mental health: risks and benefits

Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain

How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review

Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie